Renee Tannenbaum, Director at Zogenix, holds 22.62K shares in ANI Pharmaceuticals (Ticker: ANIP), holds 10.00K shares in Cardiff Oncology (Ticker: CRDF), holds 32.57K shares in Zogenix (Ticker: ZGNX).
Renee Tannenbaum latest transaction was an Uninformative Buy of ―.
What was Renee Tannenbaum's most profitable transaction?
Renee Tannenbaum’s most profitable transaction was an Informative Buy of ZGNX stock on March 20, 2017. The return on the trade was 301.80%.
What is Renee Tannenbaum's role in Zogenix?
Renee Tannenbaum's role in Zogenix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.